Anteris Technologies Ltd
ASX:AVR
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
8.8
23.55
|
Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
Anteris Technologies Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | AU |
Market Cap | 178.8m AUD |
Net Margin |
-1 231%
|
Country | JP |
Market Cap | 6.8T JPY |
Net Margin |
24%
|
Country | CH |
Market Cap | 37.9B CHF |
Net Margin |
12%
|
Country | DK |
Market Cap | 200.9B DKK |
Net Margin |
19%
|
Country | US |
Market Cap | 16.9B USD |
Net Margin |
11%
|
Country | KR |
Market Cap | 9.9T KRW |
Net Margin |
-358%
|
Country | CA |
Market Cap | 6.9B USD |
Net Margin |
-8%
|
Country | CN |
Market Cap | 48.6B CNY |
Net Margin |
42%
|
Country | US |
Market Cap | 6.3B USD |
Net Margin |
29%
|
Country | US |
Market Cap | 6.1B USD |
Net Margin |
9%
|
Country | UK |
Market Cap | 4.8B GBP |
Net Margin |
7%
|
Anteris Technologies Ltd
Glance View
Anteris Technologies Ltd. is a structural heart company, researches, develops, commercializes, and distributes various medical technologies and devices. The company is headquartered in Toowong, Queensland. The company went IPO on 2004-03-24. The firm is engaged in delivering solutions that help healthcare professionals. The firm operates through two segments: operations and projects. Operation segment provides Bio implant ADAPT operations inclusive of manufacturing and sales. Project segment includes Transcatheter Aortic Valve Replacement (TAVR), which is developed using ADAPT 3D single-piece technology and other development projects across the Company. The company offers two products, ADAPT and DurAVR. ADAPT technology is a BioScaffold, which is a tissue technology platform that demonstrates zero calcification. xenograft tissue into a pure collagen scaffold with optimized strength and pliability, biocompatibility and unparalleled durability. DurAVR heart valve Is focused on delivering a functional cure in the treatment of Severe Aortic Stenosis.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Anteris Technologies Ltd's most recent financial statements, the company has Net Margin of -1 231.2%.